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There is strong evidence that raised levels of folate 
during the periconceptional period reduces the risk 
of neural tube defects (NTDs).1,2 On 4 October 2006, 
Food Standards Australia New Zealand (FSANZ) 
released its Final Assessment Report3 presenting two 
regulatory options: mandatory fortification of 80–180 
µg of folic acid per 100 g of bread; or the maintenance 
of the current voluntary folic acid fortification 
policy, with mandatory folic acid fortification being 
the recommended option. On 25 October 2006 the 
Ministerial Council considered this mandatory folic 
acid fortification recommendation and asked FSANZ 
to review the proposed standard due to technical 
considerations with its implementation, and 
compliance issues, within 6 months. 
	
Mandatory	 folic	 acid	 fortification	 is	 a	 controversial	 policy	
and	 is	 generating	 considerable	 debate.4,5	Notwithstanding	
the	 tragic	 nature	 and	 associated	 social,	 emotional	 and	
economic	 burden	 of	 NTDs,	 mandatory	 folic	 acid	
fortification	 is	 associated	 with	 many	 scientific	 and	
ethical	 uncertainties.6	Mandatory	 fortification	will	 expose	
all	 children,	 adolescents,	 adult	 women	 and	men,	 and	
older	 people	 to	 raised	 levels	 of	 synthetic	 folic	 acid	 to	
address	a	suspected	congenital	abnormality	 in	a	relatively	
small	 number	 of	 at	 risk	 individuals.	This	 proposed	 policy	
represents	 a	 disjunction	 between	 the	medical	 nature	 of	
the	problem	and	 the	public	health	 impact	of	 the	solution.	
This	 disjunction	 casts	 doubts	 over	whether	 the	 interest	
of	 either	 the	 target	 group,	 or	 the	 population	 as	 a	whole,	
would	 be	 best	 served	 by	 this	 policy.	The	 aim	 of	 this	
article	 is	 to	contribute	 to	 the	policy	debate	particularly	by	
considering	 to	what	 extent	Hippocrates’	 principle	 of	 ‘first	
do	no	harm’	is	being	observed?	
Why has this policy debate arisen?
Mandatory	 food	 fortification	 is	 uncommon	 in	Australia,	
although	 it	 has	 been	 implemented	 when	 there	 has	
been	 strong	 evidence	 of	 population	 wide	 deficiency.	
For	 instance,	 thiamine	 is	 added	 to	 bread	making	 flour	
in	 response	 to	 evidence	 of	 suboptimal	 thiamine	 status	
within	 the	population.7,8	This	 is	 not	 the	 same	 rationale	 as	
mandatory	 folic	 acid	 fortification.	Although	 the	 biological	
mechanism	 and	 precise	 dose	 required	 for	 folic	 acid	 to	
exert	its	protective	effect	is	uncertain,	it	is	thought	to	be	a	
compensation	for	a	congenital	defect	in	at	risk	individuals.9	
The	protective	effect	is	consistent	with	a	therapeutic	type	
response	and	 is	exerted	 in	a	dose	response	relationship10	
rather	 than	 addressing	 a	 conventional	 folate	 deficiency.	
Therefore,	 mandatory	 folic	 acid	 fortification	 would	
represent	a	policy	precedent	in	Australia.	
	 The	 policy	 controversy	 is	 exacerbated	 by	 the	
existence	of	other	scientific	and	ethical	uncertainties.	For	
example,	 the	 incidence	 of	 NTDs	 has	 been	 decreasing	
in	 many	 countries	 for	 decades,	 irrespective	 of	 folic	
acid	 fortification.11	 Also,	 the	 degree	 of	 reduction	 in	
NTD	 incidence	 appears	 to	 be	 related	 to	 baseline	 NTD	
incidence.12	Moreover,	 there	has	been	 limited	support	 for	
nonfortification	 policy	 options	 in	Australia	 and	 hence	we	
have	a	 lack	of	evidence	of	the	effectiveness	of	alternative	
policy	 approaches.	 It	 is	 relevant	 to	 note	 that	 when	
preparing	 its	 recommendations	 FSANZ	 has	 a	 legislative	
requirement	 to	 consider	 a	 full	 range	of	 risk	management	
measures	and	a	regulatory	approach	should	precede	only	if	
it	is	deemed	the	most	effective	risk	management	strategy.	
The	FSANZ	risk	management	process	did	not	consider	all	
possible	strategies,	 for	example	 it	excluded	consideration	
of	 targeted	 interventions	 such	 as	 education,	 and/or	
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Viewpoint Mandatory fortification  
with folic acid
What would Hippocrates say?
In October 2006, the Australian and New Zealand Food Regulation Ministerial Council asked for a review of the proposed 
food standard permitting mandatory fortification of bread with folic acid. This article contributes to the policy debate 
associated with the standard’s review by discussing the potential benefits and risks to the target population and the 
wider Australian population with emphasis on recent (2006) literature. 
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incorporation	 of	 folic	 acid	 supplementation	 into	
best	practice	guidelines	for	practitioners.	
	 The	 central	 policy	 dilemma	 concerning	
prophylactic	 folic	acid	use	 is	 that	approximately	
half	of	all	pregnancies	are	unplanned3	and	by	the	
time	many	women	are	aware	they	are	pregnant	
the	 neural	 tube	 will	 have	 closed.	Therefore	
mandatory	 folic	 acid	 fortification	 is	 appealing	
because	 it	 ensures	 passive	 exposure	 by	 the	
target	 group,	 requiring	 no	 behaviour	 change	
during	 the	 critical	 periconceptional	 period.	
Also,	 it	 is	 equitable;	 all	women	 regardless	 of	
background	or	 circumstances	will	 be	exposed.6	
Paradoxically,	its	appeal	is	a	double	edged	sword.	
Because	the	intervention	is	nondiscriminating,	it	
will	expose	the	entire	bread	eating	population	to	
raised	levels	of	synthetic	folic	acid.	
Hippocrates and potential benefits/risks 
for the target population 
An	evaluation	of	mandatory	folic	acid	fortification	
of	enriched	grains	in	the	United	States	reported	
a	27%	reduction	in	NTDs	since	the	introduction	
of	 the	 intervention.13	However,	when	preparing	
its	 policy	 recommendations,	 FSANZ	 was	
confronted	 with	 the	 dilemma	 that	 both	 the	
Australian	National	Health	and	Medical	Research	
Council	 and	 the	US	 Institute	 of	Medicine	 have	
set	 an	 upper	 limit	 of	 intake	 of	 folic	 acid	 of	 1	
mg/day	 due	 to	 its	 potential	 to	 precipitate	 or	
exacerbate	neuropathy	 in	 vitamin	B12	deficient	
individuals.14,15	 In	 recognition	 of	 this	 concern,	
FSANZ	has	proposed	a	 fortification	 level	 of	80–
180	 µg	 folic	 acid	 per	 100	 g	 of	 bread.3	At	 this	
level	of	fortification,	FSANZ	predicts	that	26	NTD	
conceptions	 (95%	CI:	 14–49),	 or	 approximately	
8%	 of	 the	 300–350	 pregnancies	 affected	 by	
NTDs	 in	Australia	 each	 year	will	 be	 prevented.	
Critically,	 targeted	 folic	 acid	 supplementation	
would	 avoid	 this	 dosage	 constraint;	 this	
potentially	would	 have	 a	 greater	 reduction	 of	
risk.	Folic	acid	supplementation	is	not	associated	
with	a	reduction	in	nonneural	birth	defects.16
	 The	principal	potential	 risk	 identified	 for	 the	
target	 group	 is	multiple	 births.	While	 there	 is	
some	conjecture	over	this	risk	(the	relationship	
marginally	misses	 out	 on	 significance	 [1.40:	
0.93–2.31]17),	 the	 authors	 observed	 the	
findings	were	consistent	with	other	studies	and	
worthy	 of	 concern;	 a	 conclusion	 that	 persists	
among	others.18	
Hippocrates and potential benefits/risks 
for the wider population
Given	that	20	million	Australians	will	be	exposed	
to	 significantly	 raised	 levels	 of	 synthetic	 folic	
acid	 for	 the	 first	 time	 in	 evolutionary	 history,	
it	 is	 of	 importance	 to	 consider	 its	 impact	 on	
the	 health	 of	 the	wider	 population.	Additional	
folic	 acid	 intake	 has	 been	 hypothesised	
to	 be	 advantageous	 to	 the	wider	 population	
–	 by	 lowering	plasma	homocysteine	 levels	 and	
thereby	 reducing	 cardiovascular	 disease	 risk,	
by	 improving	cognitive	 function,	and	by	helping	
to	 prevent	 some	 types	 of	 cancer.	 In	 its	 Final	
Assessment	 Report,	 FSANZ	 draws	 attention	
specifically	 to	 these	 three	 potential	 benefits.3	
However,	 the	 findings	 of	 several	 recent	 (2006)	
studies	 now	 refute	 these	 hypotheses	 and	
suggest	that	elevated	folic	acid	status	may	be	a	
potential	risk	for	these	conditions.19–24	
	 In	 the	 case	of	 cardiovascular	 disease,	 three	
large,	multicentred,	 randomised	controlled	 trials	
have	 failed	 to	 demonstrate	 a	 benefit	 of	 folic	
acid	 supplementation.19–21	Moreover,	 potential	
harm	was	 observed	 in	 one	 study	with	 a	 near	
significant	 increase	 in	myocardial	 infarctions.19	
A	 recent	 2	 year	 randomised	 controlled	 trial	 of	
folic	 acid	supplementation	 found	no	evidence	of	
a	positive	effect	on	 cognition	 in	 the	elderly	 and	
provided	 evidence	 of	 a	 statistically	 significant	
decline	 in	 information	 processing	 speed	with	
supplementation.22	A	European	longitudinal	study	
observed	a	significant	increased	risk	of	colorectal	
cancer	 in	 individuals	 with	 the	 highest	 folate	
intakes	 over	 a	 4.2	 year	 period.23	 In	 a	 separate	
USA	cohort	 study,	 high	 folate	 intakes	 attributed	
to	supplemental	 folic	acid,	were	associated	with	
a	 significant	 increased	 risk	 of	 breast	 cancer.24	
Another	USA	study	identified	unmetabolised	folic	
acid	in	the	circulation	of	78%	of	postmenopausal	
women	and	that	there	was	an	inverse	relationship	
between	this	and	a	measure	of	immunity	(natural	
killer	cell	cytotoxicity).25
	 It	 is	 often	 argued	 that	 there	 have	 been	 no	
identified	 risks	 overseas	 –	 however,	 a	 strong	
advocate	 for	mandatory	 fortification	with	 folic	
acid	 in	 the	USA	 has	 conceded	 that	 adequate	
monitoring	mechanisms	were	 not	 put	 in	 place	
to	be	so	confident	with	such	an	assessment.26	
Potential	 benefits	 and	 risks	 associated	with	
mandatory	 fortification	 with	 folic	 acid	 are	
summarised	in	Table 1.
The policy debate
Given	 the	many	 uncertainties	 associated	with	
mandatory	 folic	 acid	 fortification,	 we	 offer	
the	 following	 suggestions	 to	 help	 inform	 this	
policy	debate.
Infrastructure to support data collection and 
management 
It	 is	 over	 10	 years	 since	 the	 last	 national	
nutrition	 survey	was	 conducted	 and	 the	 data	
on	 folate	 consumption	 patterns	 and	 folate	
status	 are	 outdated.	 In	 addition,	 there	 are	
incomplete	 data	 on	 the	 folate	 composition	 of	
food	products.	Together	 this	 lack	of	 information	
does	not	bode	well	for	 informed	policy	making,	
nor	will	 authorities	 be	well	 placed	 to	 evaluate	
the	 outcome	 of	 any	 policy	 decision.	 Also,	 a	
comprehensive	 risk-benefit	 analysis	 –	 that	
includes	 data	 from	 the	 most	 recent	 (2006)	
studies	–	needs	to	be	undertaken.	
	 Should	 mandatory	 fortification	 with	 folic	
acid	 be	 approved,	 it	 is	 essential	 that	 there	
be	 adequate	 monitoring	 and	 evaluation	 of	
this	 intervention.	 Unfortunately,	 previous	
experience	 in	 this	 area	 does	not	 augur	well	 as	
few	 resources	were	 provided	 for	monitoring	
and	 evaluating	 voluntary	 folate	 fortification.27	
Monitoring	 and	evaluation	will	 be	 a	 challenging	
task	 given	 the	 uncertainties	 associated	with	
this	 policy	 topic.	There	 is	 the	 dilemma	 of	 not	
knowing	 the	 long	 term	 health	 implications	 of	
the	presence	of	elevated	unmetabolised	plasma	
folic	acid	levels.	
Support the promotion of targeted 
supplementation
Governments	 should	 invest	 more	 resources	
supporting	 a	 program	 for	 targeted	 folic	 acid	
supplementation	and	greater	public	education	on	
the	 importance	of	 periconceptional	 use	of	 folic	
acid.	 Incorporation	of	 folic	 acid	supplementation	
into	best	 practice	guidelines	 for	 practitioners	 is	
also	 required.	This	approach	has	 the	advantages	
of	not	 inadvertently	 inflicting	harm	on	 the	wider	
population,	 targeting	 the	 intervention	 to	 at	 risk	
individuals	 and	 delivering	 the	 recommended	
dose.	 Indeed,	 a	 randomised	 controlled	 trial	 of	
a	 targeted	 folic	 acid	 supplementation	 program	
administered	by	physicians	 in	 the	USA	reported	
higher	effectiveness	than	mandatory	fortification	
with	folic	acid.28	
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	 Although	 FSANZ	 has	 identified	 in	 its	
Final	 Assessment	 Report	 the	 importance	 of	
these	 two	 activities,	 it	 also	 states	 that	 their	
establishment	 and	 funding	 extends	 beyond	 its	
statutory	 responsibilities.3	As	 such	 there	 are	
no	 guarantees	 that	 they	will	 be	 implemented	
should	 mandatory	 folic	 acid	 fortification	 be	
permitted.	This	 is	 due	 to	 the	 separation	 of	
the	 technical	 responsibilities	 from	 the	 policy	
responsibilities	 of	 FSANZ	 and	 the	Ministerial	
Council	respectively.	Therefore,	if	education	and	
monitoring	 and	 evaluation	 activities	 are	 to	 be	
adequately	 considered,	 they	will	 need	 to	 be	
integral	components	of	the	policy	decision	made	
by	the	Ministerial	Council.
Conclusion
Mandatory	 folic	 acid	 fortification	 in	 order	 to	
reduce	 the	 risk	of	NTDs	 is	a	 far	more	complex	
and	 challenging	 policy	 debate	 than	 is	 often	
recognised.	We	 all	 want	 simple	 answers	 to	
tragic	 circumstances,	 and	 as	 compelling	 as	
this	 policy	 first	 appears,	 it	 is	 important	 that	
the	potential	 risks	don’t	outweigh	any	potential	
benefits.	 In	 lieu	 of	 the	 many	 scientific	 and	
ethical	uncertainties	associated	with	this	policy,	
we	wonder	what	Hippocrates	would	 have	 said	
about	this	policy	debate?	
	 The	 predicted	 prevention	 of	 26	 NTD	
conceptions	 represents	 8%	 of	 al l 	 NTD	
conceptions	each	year	in	Australia.	At	the	same	
time,	 20	million	Australians	will	 be	 exposed	 to	
raised	 levels	 of	 synthetic	 folic	 acid	 for	which	
the	ethical	 and	potential	 risk	 implications	 need	
to	 be	 considered	 carefully.	This	 is	 a	 topic	 that	
generates	 strong	 emotions	 and	 presents	
peculiar	 dilemmas	 and	 challenges	 for	 policy	
makers.	 It	 brings	 together	 a	 public	 health	
nutrition	 approach	 to	 address	 a	 tragic	medical	
issue.	Our	concern	is	that	this	disjunction	might	
result	 in	 an	 outcome	 that	 both	 compromises	
effectiveness	 and	 presents	 a	 potentially	
greater	 risk	 than	 benefit.	We	believe	 a	 greater	
reduction	in	NTD	conceptions	could	be	achieved	
with	 a	 well	 resourced	 targeted	 folic	 acid	
supplementation	program	promotion.
	 This	need	 for	caution	 is	all	 the	more	salient	
given	 the	 lack	 of	 nutrition	 baseline	 information	
available	 in	Australia.	 It	might	be	cautionary	 for	
the	policy	decision	to	be	delayed	until	adequate	
information,	 including	 the	 findings	 from	 a	
comprehensive	risk-benefit	analysis,	is	available.	
If	mandatory	 folic	 acid	 fortification	 is	 approved	
by	 the	Ministerial	 Council	 it	 is	 essential	 that	
there	 be	 adequate	monitoring	 and	 evaluation.	
Faced	 with	 the	 many	 scientific	 and	 ethical	
dilemmas	associated	with	this	topic,	we	believe	
more	 information	would	 help	 decision	makers	
move	 closer	 to	 a	 precautionary	 approach	 to	
resolve	this	vexed	policy	debate.
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